secwatch.observer — SEC 8-K summary
======================================

Issuer:     Twist Bioscience Corp (TWST)
CIK:        0001581280
Form:       8-K
Filed at:   2022-11-18T23:59:59+00:00
Accession:  0001104659-22-120392
Event type: other
Sentiment:  positive
Materiality: 0.40
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Twist Bioscience amends bylaws to add proxy access for 3% long-term stockholders
--------------------------------------------------------------------------------

- Proxy access provision allows stockholders/groups of up to 20 owning ≥3% for ≥3 years to nominate up to 2 or 20% of directors.
- Deleted requirement for stockholder list examination at meetings to conform to recent Delaware law changes.
- Added universal proxy rule requirements: nominating stockholders must confirm solicitation from ≥67% of voting power and provide evidence.
- Other technical, conforming, and non-substantive changes included.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1581280/000110465922120392/0001104659-22-120392-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1581280/000110465922120392/tm2230963d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-120392

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer